BOLT
Bolt Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.91
-0.14 ▼ -3.46%
🌙 3월 13일 4:25 PM ET (한국 3/14 05:25)
$3.82
-0.09 ▼ -2.30%
| Index | - | P/E | - | EPS (ttm) | -17.78 | Insider Own | 21.34% | Shs Outstand | 0.00B | Perf Week | -9.07% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | -12.86% | Insider Trans | 0.12% | Shs Float | 0.00B | Perf Month | -21.8% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -2.85 | Inst Own | 10.85% | Short Float | 0.12% | Perf Quarter | -32.59% |
| Income | -0.03B | P/S | 0.98 | EPS this Y | -22.8% | Inst Trans | -12.54% | Short Ratio | 0.07 | Perf Half Y | -25.81% |
| Sales | 0.01B | P/B | 0.28 | EPS next 5Y | -19.99% | ROA | -41.2% | Short Interest | 0.00M | Perf YTD | -28.49% |
| Book/sh | 13.8 | P/C | 0.27 | EPS past 3/5Y | 27.67% 11.84% | ROE | -79.75% | 52W High | -59.52% ($9.66) | Perf Year | -53.31% |
| Cash/sh | 14.42 | P/FCF | - | Sales past 3/5Y | 10.33% 101.61% | ROIC | -71.57% | 52W Low | -2.49% ($4.01) | Perf 3Y | -86.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.83% | Gross Margin | 83.22% | Volatility(W/M) | 7.02% 8.08% | Perf 5Y | -99.5% |
| Dividend TTM | - | EV/Sales | 0.36 | Sales Y/Y TTM | 0.07% | Oper. Margin | -450.07% | ATR (14) | 0.38 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.57 | EPS Q/Q | 53.88% | Profit Margin | -433.74% | RSI (14) | 30.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.57 | Sales Q/Q | - | SMA20 | -14.33% ($4.56) | Beta | 0.87 | Target Price | $41 |
| Payout | - | Debt/Eq | 0.87 | Earnings | 3000000 | SMA50 | -27.56% ($5.4) | Rel Volume | 1.05 | Prev Close | $4.05 |
| Employees | 23 | LT Debt/Eq | 0.76 | EPS/Sales Surpr. | 37.12% 274.98% | SMA200 | -28.96% ($5.5) | Avg Volume(3M) | 0.03M | Price | $3.91 |
| IPO | 2021/2/5 | Option/Short | No/Yes | Trades | 331 | Volume | 29,072 | Change | -3.46% |
뉴스 로딩 중...